Omeros Corp. (OMER)
8.67
-2.05
(-19.12%)
USD |
NASDAQ |
Jun 26, 16:00
8.59
-0.08
(-0.92%)
After-Hours: 20:00
Omeros Cash from Financing (TTM) : -55.93M for March 31, 2026
Cash from Financing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -55.93M |
| December 31, 2025 | -35.79M |
| September 30, 2025 | 18.18M |
| June 30, 2025 | -12.23M |
| March 31, 2025 | -37.39M |
| December 31, 2024 | 62.88M |
| September 30, 2024 | -37.98M |
| June 30, 2024 | -33.88M |
| March 31, 2024 | -7.265M |
| December 31, 2023 | -106.08M |
| September 30, 2023 | -1.782M |
| June 30, 2023 | 123.54M |
| March 31, 2023 | 123.70M |
| December 31, 2022 | 124.25M |
| September 30, 2022 | 124.09M |
| June 30, 2022 | -0.27M |
| March 31, 2022 | 0.684M |
| December 31, 2021 | 6.319M |
| September 30, 2021 | 6.966M |
| June 30, 2021 | 178.94M |
| March 31, 2021 | 177.93M |
| December 31, 2020 | 174.53M |
| September 30, 2020 | 231.17M |
| June 30, 2020 | 61.78M |
| March 31, 2020 | 63.24M |
| Date | Value |
|---|---|
| December 31, 2019 | 60.70M |
| September 30, 2019 | 29.69M |
| June 30, 2019 | 30.34M |
| March 31, 2019 | 75.68M |
| December 31, 2018 | 76.37M |
| September 30, 2018 | 52.01M |
| June 30, 2018 | 116.67M |
| March 31, 2018 | 74.44M |
| December 31, 2017 | 75.00M |
| September 30, 2017 | 82.69M |
| June 30, 2017 | 51.78M |
| March 31, 2017 | 68.18M |
| December 31, 2016 | 68.70M |
| September 30, 2016 | 69.81M |
| June 30, 2016 | 30.56M |
| March 31, 2016 | 7.783M |
| December 31, 2015 | 86.83M |
| September 30, 2015 | 77.72M |
| June 30, 2015 | 79.78M |
| March 31, 2015 | 82.28M |
| December 31, 2014 | 50.86M |
| September 30, 2014 | 55.51M |
| June 30, 2014 | 55.26M |
| March 31, 2014 | 70.86M |
| December 31, 2013 | 21.65M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
| Novo Nordisk A/S | -4.809B |
| Phibro Animal Health Corp. | -12.71M |
| Eli Lilly & Co. | -7.063B |
| ANI Pharmaceuticals, Inc. | -21.65M |
| Corcept Therapeutics, Inc. | -179.80M |